FunPep

Notice Concerning Commencement of Research on Alzheimer’s Disease Vaccine

Exercise of Option by MEDIPAL HOLDINGS CORPORATION

Announcement of Newly Developed Compound for Antibody-Inducing Peptide against Pollinosis

Notice of participation in “BIO 2023”

We are pleased to announce that we will participate in the BIO International Convention, one of the largest partnering events in the healthcare industry held in the U.S., with the objective of collaborating on the development of antibody-inducing peptides*.
* https://www.funpep.co.jp/en/antibody-inducing-peptide

Date:　 June 5–8, 2023
Location： Boston Convention & Exhibition Center in Boston, MA

Company Presentation
Date & Time：June 5, 3:00 PM EDT
Room：104A

the BIO International Convention
https://www.bio.org/events/bio-international-convention

Notice of participation in “Japan Innovation Night”

We are pleased to announce that we will participate in the Japan Innovation Night organized by JETRO and Cambridge Innovation Center (CIC) on the final day of BIO 2023 and make a pitch presentation for our peptide technology.

Date & Time：June 8, 4:00 PM EDT – 8:00 PM EDT
Location：Cambridge Innovation Center (1 Broadway, Cambridge, MA)

the Japan Innovation Night
https://venturecafecambridge.org/event/japan-innovation-night-3/

Announcement of Preliminary Results of Phase I/IIa Clinical Trial of Antibody Inducing Peptide FPP003